In conclusion, the result of our study suggested that CAPE partly exerts its antimetastatic effects on oral cancer cells by regulating MMP-2 expression through the inhibition of FAK and MAPK activation. The gene discussed is PTK2; the disease is lip and oral cavity carcinoma.